Skip to content
My WebMD Sign In, Sign Up

Bladder Cancer Health Center

Font Size

Urethral Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Recurrent or Metastatic Urethral Cancer

Local recurrences of urethral cancer may be amenable to local modality therapy with radiation or surgery, with or without chemotherapy. (Refer to the Treatment Option Overview section of this summary for more information.) Metastatic disease may be treated with regimens in common use for other urothelial transitional cell or squamous cell carcinomas, or anal carcinomas, depending upon the histology.[1,2,3]

Treatment options:

Recommended Related to Bladder Cancer

Understanding Bladder Cancer -- Prevention

To prevent bladder cancer, your best bet is to avoid possible carcinogens, or cancer-causing substances. For starters, don't smoke. Eat smoked or cured meats only occasionally and prepare fresh rather than processed foods. Research also suggests that there is a reduced incidence of bladder cancer among people with adequate vitamin B-6, beta-carotene, and selenium in their diets. If you work around carcinogenic chemicals, follow safety guidelines to avoid undue exposure. And if you feel you may be...

Read the Understanding Bladder Cancer -- Prevention article > >

  1. Locally recurrent urethral cancer after radiation therapy should be treated by surgical excision, if feasible.
  2. Locally recurrent urethral cancer after surgery alone should be considered for combination radiation and wider surgical resection.
  3. Metastatic urethral cancer should be considered for clinical trials using chemotherapy. Transitional cell cancer of the urethra may respond favorably to the same chemotherapy regimens employed for advanced transitional cell cancer of the bladder.[2,3,4,5]

The level of evidence for these treatment options is 3iiiDiv.

Current Clinical Trials

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent urethral cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site.

References:

  1. Trabulsi DJ, Gomella LG: Cancer of the urethra and penis. In: DeVita VT Jr, Lawrence TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp 1272-79.
  2. Trabulsi EJ, Hoffman-Censits J: Chemotherapy for penile and urethral carcinoma. Urol Clin North Am 37 (3): 467-74, 2010.
  3. Lin CC, Hsu CH, Huang CY, et al.: Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma. J Urol 177 (1): 84-9; discussion 89, 2007.
  4. Trabulsi EJ, Gomella LG: Cancer of the urethra and penis. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds.: Cancer: Principles and Practice of Oncology. Vols. 1 & 2. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2008, pp 1452-62.
  5. VanderMolen LA, Sheehy PF, Dillman RO: Successful treatment of transitional cell carcinoma of the urethra with chemotherapy. Cancer Invest 20 (2): 206-7, 2002.
1

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Integrative Medicine Cancer Quiz
QUIZ
what is your cancer risk
HEALTH CHECK
 
cancer fighting foods
SLIDESHOW
Bladder Cancer Why More Men May Be At Risk
VIDEO
 
Lifestyle Tips for Depression Slideshow
SLIDESHOW
Bladder Sparing Cancer Treatment
VIDEO
 
Vitamin D
SLIDESHOW
Pets Improve Your Health
SLIDESHOW
 

WebMD Special Sections